News: Year - 2017

Press Releases
Kane Biotech – Q3 2017 Financial Results, Resignation of Director and Granting of Options

Kane Biotech – Q3 2017 Financial Results, Resignation of Director and Granting of Options

WINNIPEG, Manitoba – (GlobeNewswire – November 14, 2017) – Kane Biotech Inc. (TSX-V:KNE) (the “Corporation” or “Kane Biotech”) is pleased to announce its Q3…

> Read More

Press Releases
Kane Biotech Inc. Provides Overview of Biofilm Industry, Clinical Development and Growth Drivers in New SNNLive Video Interview with StockNewsNow.com

LOS ANGELES, CA / ACCESSWIRE / October 30, 2017 / StockNewsNow.com, The Official MicroCap News Source™, today published an SNNLive Video Interview with Mark Ahrens-Townsend, President and CEO of Kane Biotech Inc. (TSX-V: KNE). Kane Biotech is a…

> Read More

Press Releases
Kane Biotech Announces New Chief Financial Officer

Kane Biotech Announces New Chief Financial Officer

WINNIPEG, Manitoba – GlobeNewsWire – September 5, 2017

Kane Biotech Inc. (TSX-V:KNE) (the “Company” or “Kane Biotech”) today announced the appointment of Ray Dupuis as Chief Financial Officer.

Mr. Dupuis has more than…

> Read More

Press Releases
Kane Biotech Announces Second Closing of Private Placement Offering and Resignation of Director

Kane Biotech Announces Second Closing of Private Placement Offering and Resignation of Director

WINNIPEG, Manitoba – August 18, 2017 – Kane Biotech Inc. (TSX-V:KNE) (the “Company” or “Kane Biotech”) today announced that it has completed the…

> Read More

Press Releases
Kane Biotech – Q2 2017 Financial Results

WINNIPEG, Manitoba – (GlobalNewsWired – August 16, 2017) – Kane Biotech Inc. (TSX-V:KNE) (the “Corporation” or “Kane Biotech”) is pleased to announce its Q2 2017 Financial Results.

Highlights:

Total Revenues:

For the six months ended June 30, 2017 were $890,906, an…

> Read More

Press Releases
Kane Biotech Announces Removal of All Debt from its Balance Sheet and Grant of Options

Kane Biotech Announces Removal of All Debt from its Balance Sheet and Grant of Options

WINNIPEG, Manitoba – (Marketwired – July 24, 2017) – Kane Biotech Inc. (TSX-V:KNE) (the “Company” or “Kane Biotech”) today announced it has paid out all…

> Read More

Press Releases
Kane Biotech Announces Closing of Over-Sold Private Placement Offering

Kane Biotech Announces Closing of Over-Sold Private Placement Offering

WINNIPEG, Manitoba – July 17, 2017 – Kane Biotech Inc. (TSX-V:KNE) (the “Company” or “Kane Biotech”) today announced that it has closed its previously announced private placement offering (the “Offering”) of…

> Read More

Press Releases
Kane Biotech Announces Closing of Loan Transaction

WINNIPEG, Manitoba – (Marketwired – June 27, 2017) – Kane Biotech Inc. (TSX-V:KNE) (the “Company” or “Kane Biotech”) today announced that it has received a loan (the “Loan”) in the amount of $400,000 from Individual Investment Corporation, an arm’s length…

> Read More

Press Releases
Kane Biotech Announces Private Placement Offering

WINNIPEG, Manitoba – (Marketwired – June 1, 2017) – Kane Biotech Inc. (TSX-V:KNE) (the “Company” or “Kane Biotech”) today announced the intention of the Company to undertake a non-brokered private placement offering (the “Offering”) of up to 33,333,333 units (“Units”)…

> Read More